Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent
| Image |  |
|---|---|
| Description | scientific article published on 14 January 2020 |
| Author/s |
author: Hiroshi Sugimoto Osamu Kurasawa |
| Publication date | January 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |